Haleon plc (HLN) ORD GBP0.01

Sell:390.70pBuy:391.00p4.60p (1.19%)

Prices delayed by at least 15 minutes
Sell:390.70p
Buy:391.00p
Change:4.60p (1.19%)
Prices delayed by at least 15 minutes
Sell:390.70p
Buy:391.00p
Change:4.60p (1.19%)
Prices delayed by at least 15 minutes

Company Information

About this company

Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Key people

Brian Mcnamara
Chief Executive Officer, Executive Director
Dawn Amanda Allen
Chief Financial Officer, Executive Director
Keith Choy
President, Asia Pacific
Filippo Lanzi
President, EMEA and LatAm
Lisa Paley
President, North America
Line De Decker
Chief Human Resource Officer
Tamara Rogers
Chief Marketing Officer
Bjarne Philip Tellmann
General Counsel
Namrata Patel
Chief Supply Chain Officer
Ed Petter
Chief Corporate Affairs Officer
Dave Lewis
Independent Non-Executive Chairman of the Board
Bryan Supran
Non-Executive Director
Nancy Avila
Non-Executive Independent Director
Marie-Anne Aymerich
Non-Executive Independent Director
Manvinder Singh Banga
Senior Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    HLN
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BMX86B70
  • Market cap
    £35.32bn
  • Employees
    24,000
  • Shares in issue
    9.05bn
  • Exchange
    London Stock Exchange (LON)
  • Index
    FTSE All Share Index, FTSE 100 Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.